+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Middle East & Africa Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class; Route of Administration; Application; and Distribution Channel, and Country

  • PDF Icon

    Report

  • 140 Pages
  • November 2020
  • Region: Africa, Middle East
  • The Insight Partners
  • ID: 5231456
UP TO OFF until Jun 30th 2024
According to the publisher's new market research study on “Middle East & Africa Gastrointestinal Drugs Market to 2027 - Regional Analysis and Forecast - by Drug Class, Route of Administration, Application, and Distribution Channel” the market is expected to reach US$ 2,573.94 million by 2027 from US$ 2,000.27 million in 2019; it is estimated to grow at a CAGR of 3.3% from 2020 to 2027. The report provides trends prevailing in the Middle East & Africa gastrointestinal drugs market and the factors driving the market growth along with those hindering it.

In 2019, the acid neutralizers segment accounted for the highest share of the market. However, the biologics segment is expected to be the fastest-growing during the forecast period. The CAGR of the biologics segment has the highest CAGR in the forecast period. The growth of the segment is attributed to growing product development and increasing product launches in the market.

The growth of the Middle East & Africa gastrointestinal drugs market is mainly attributed to rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics. However, low awareness associated with gastrointestinal disorders in low-income economies will restrict the market growth.

GlaxoSmithKline plc; Celltrion Healthcare Co., Ltd.; Johnson and Johnson Services, Inc.; AstraZeneca; and Takeda Pharmaceutical Company Limited are among the leading companies operating in the Middle East & Africa Gastrointestinal Drugs market.

The Report Segments Middle East & Africa Gastrointestinal Drugs Market as Follows:

Middle East & Africa Gastrointestinal Drugs Market - By Drug Class
  • Acid Neutralizers
  • Antidiarrheal and Laxatives
  • Anti-Inflammatory Drugs
  • Antiemetic and Antinauseants
  • Biologics
  • Others

Middle East & Africa Gastrointestinal Drugs Market - By Route of Administration
  • Oral
  • Parenteral

Middle East & Africa Gastrointestinal Drugs Market - By Application
  • Inflammatory Ulcerative Colitis
  • Crohn's Disease
  • Irritable Bowel Syndrome
  • Gastroenteritis
  • Celiac Disease
  • Others

Middle East & Africa Gastrointestinal Drugs Market - By Country
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East and Africa

Reasons to Buy
  • It provides understanding of the Middle East & Africa, gastrointestinal drugs market landscape and identifies gastrointestinal drugs market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East & Africa gastrointestinal drugs market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the gastrointestinal drugs market by identifying market segments with the most promising probable sales It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of gastrointestinal drugs market performance of various segments pertaining to the Middle East & Africa gastrointestinal drugs market.
  • It provides gastrointestinal drugs market revenue forecast of the market based on various segments for the period from 2019 to 2027.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Gastrointestinal Drugs Market - by Drug Class
1.3.2 Middle East and Africa Gastrointestinal Drugs Market - by Route of Administration
1.3.3 Middle East and Africa Gastrointestinal Drugs Market - by Application
1.3.4 Middle East and Africa Gastrointestinal drugs Market - by Distribution Channel
1.3.5 Middle East and Africa Gastrointestinal drugs Market - by Country
2. Middle East and Africa Gastrointestinal Drugs Market Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Gastrointestinal Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Gastrointestinal Drugs Market - Middle East and Africa PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Gastrointestinal Drugs Market Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal (GI) Diseases
5.1.2 Increase in Development of Biologics
5.2 Market Restraints
5.2.1 Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies
5.3 Market Opportunities
5.3.1 Increasing Investment in Research Activities and Growing Pipeline of GI Candidates
5.4 Future Trends
5.4.1 Emergence of Biosimilars
5.5 Impact Analysis
6. Gastrointestinal Drugs Market - Middle East and Africa Analysis
6.1 Middle East and Africa Gastrointestinal Drugs Market Revenue Forecasts and Analysis
7. Middle East and Africa Gastrointestinal Drugs Market Analysis and Forecasts to 2027 - by Drug Class
7.1 Overview
7.2 Middle East and Africa Gastrointestinal Drugs Market, by Drug Class 2019 & 2027 (%)
7.2.1 Middle East and Africa Gastrointestinal drugs Market Revenue and Forecasts to 2027, by Drug Class (US$ Mn)
7.3 Acid Neutralizers
7.3.1 Overview
7.3.2 Middle East and Africa Acid Neutralizers Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Antidiarrheal and Laxatives
7.4.1 Overview
7.4.2 Middle East and Africa Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Anti-Inflammatory Drugs
7.5.1 Overview
7.5.2 Middle East and Africa Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Antiemetic and Antinauseants
7.6.1 Overview
7.6.2 Middle East and Africa Antiemetic and Antinauseants Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Biologics
7.7.1 Overview
7.7.2 Middle East and Africa Biologics Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Others
7.8.1 Overview
7.8.2 Middle East and Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Middle East and Africa Gastrointestinal Drugs Market Analysis - by Route of Administration
8.1 Overview
8.2 Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration 2019-2027 (%)
8.2.1 Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Route of Administration (US$ Mn)
8.3 Oral
8.3.1 Overview
8.3.2 Middle East and Africa Oral Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Parenteral
8.4.1 Overview
8.4.2 Middle East and Africa Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)
9. Middle East and Africa Gastrointestinal Drugs Market Analysis - by Application
9.1 Overview
9.2 Middle East and Africa Gastrointestinal Drugs Market, by Application 2019-2027 (%)
9.2.1 Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Application (US$ Mn)
9.3 Inflammatory Ulcerative Colitis
9.3.1 Overview
9.3.2 Middle East and Africa Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Crohn's Disease
9.4.1 Overview
9.4.2 Middle East and Africa Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Irritable Bowel Syndrome
9.5.1 Overview
9.5.2 Middle East and Africa Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Gastroenteritis
9.6.1 Overview
9.6.2 Middle East and Africa Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Celiac Disease
9.7.1 Overview
9.7.2 Middle East and Africa Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 Middle East and Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Middle East and Africa Gastrointestinal Drugs Market Analysis - by Distribution Channel
10.1 Overview
10.2 Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel 2019-2027 (%)
10.2.1 Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Distribution Channel (US$ Mn)
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.2 Middle East and Africa Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Retail Pharmacies
10.4.1 Overview
10.4.2 Middle East and Africa Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Online Pharmacies
10.5.1 Overview
10.5.2 Middle East and Africa Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
11. Gastrointestinal Drugs Market Revenue and Forecasts to 2027 - Geographical Analysis
11.1 Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027
11.1.1 Overview
11.1.2 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
11.1.2.1 Middle East & Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.1.2.2 Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.1.2.3 Middle East & Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.2.4 Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.3 Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
11.1.3.1 Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.3.1.1 Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.3.2 Saudi Arabia Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.1.3.3 Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027(USD Million)
11.1.3.4 Saudi Arabia Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.3.5 Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.3.6 UAE: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.3.6.1 UAE: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.3.7 UAE Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.1.3.8 UAE Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.1.3.9 UAE Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.3.10 UAE Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.2 South Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
11.2.1 South Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.1.1 South Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.2.1.2 South Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.2.1.3 South Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.2.1.4 South Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.3 Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
11.3.1 Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.1.1 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.3.1.2 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.3.1.3 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.3.1.4 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
12. Impact of COVID-19 Pandemic on Middle East and Africa Gastrointestinal Drugs Market
12.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13. Company Profiles
13.1 Takeda Pharmaceutical Company Limited
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Celltrion Healthcare Co.,Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 AstraZeneca
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 Glossary of Terms
List of Tables
Table 1. Middle East and Africa Gastrointestinal drugs Market Revenue and Forecasts to 2027, by Drug Class (US$ Mn)
Table 2. Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Route of Administration (US$ Mn)
Table 3. Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Application (US$ Mn)
Table 4. Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Distribution Channel (US$ Mn)
Table 5. Middle East & Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 6. Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 7. Middle East & Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 8. Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 9. Saudi Arabia Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 10. Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 11. Saudi Arabia Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 12. Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. UAE Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 14. UAE Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 15. UAE Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 16. UAE Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 17. South Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 18. South Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 19. South Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. South Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 21. Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 22. Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 23. Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 24. Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 25. Glossary of Terms, Gastrointestinal Drugs Market
List of Figures
Figure 1. Gastrointestinal Drugs Market Segmentation
Figure 2. Middle East and Africa Gastrointestinal Drugs Market Overview
Figure 3. Acid Neutralizers Segment Held Largest Share of Product in Gastrointestinal Drugs Market
Figure 4. Saudi Arabia is Expected to show Remarkable Growth during the Forecast Period
Figure 5. Middle East and Africa Gastrointestinal Drugs Market - Leading Country Markets (US$ Mn)
Figure 6. Gastrointestinal Drugs Market - Middle East and Africa PEST Analysis
Figure 7. Gastrointestinal Drugs Market Impact Analysis of Drivers and Restraint
Figure 8. Middle East and Africa Gastrointestinal Drugs market - Revenue Forecasts and Analysis-2019-2027
Figure 9. Middle East and Africa Gastrointestinal Drugs Market, by Drug Class 2019 & 2027 (%)
Figure 10. Middle East and Africa Acid Neutralizers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Middle East and Africa Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Middle East and Africa Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Middle East and Africa Antiemetic and Antinauseants Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Middle East and Africa Biologics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Middle East and Africa Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration 2019 & 2027 (%)
Figure 17. Middle East and Africa Oral Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Middle East and Africa Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Middle East and Africa Gastrointestinal Drugs Market, by Application 2019 & 2027 (%)
Figure 20. Middle East and Africa Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Middle East and Africa Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Middle East and Africa Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Middle East and Africa Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Middle East and Africa Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Middle East and Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel 2019 & 2027 (%)
Figure 27. Middle East and Africa Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Middle East and Africa Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Middle East and Africa Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Middle East & Africa: Gastrointestinal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 31. Middle East & Africa Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 32. Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
Figure 33. Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. UAE: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. South Africa Gastrointestinal drugs market Revenue and Forecasts to 2027 (US$ Mn)
Figure 36. Rest of Middle East and Africa Gastrointestinal drugs market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Middle East and Africa

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Johnson and Johnson Services, Inc.
  • GlaxoSmithKline plc
  • Celltrion Healthcare Co.,Ltd.
  • AstraZeneca
  • Takeda Pharmaceutical Company Limited